This week in Cheap Seats: Stocks Under $20 segment, we're taking a look at online services stocks GoodRx Holdings Inc (NASDAQ:GDRX) and Bumble Inc (NASDAQ:BMBL).
GoodRx stock is surging today, up 8.8% at $7.91 at last look, after an upgrade from Raymond James to "outperform" from "market perform," with a price-target hike to $16 from $14. This bull note follows the healthcare platform's inaugural investor day and prescription contracting agreement with supermarket chain Kroger (KR). Since the start of the year, the equity is up 18.2%.
Bumble stock isn't making any particularly outsized moves today, up 0.2% at $11.99. However, the stock is on a notable uptrend after its May 8 record low of $9.83. BMBL jumped broke above several short-term moving averages following this trough, including former pressure at the 60-day trendline.
It's also worth mentioning that both stocks have a bit of short squeeze potential. Short interest represents 10.8% of GDRX's available float, and 9.3% of BMBL's.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
